The generic drug companies have a simple idea: lower the price of generic drugs.
This is good news for the industry, as it means fewer people will have to pay for expensive drugs.
However, the industry has also been slow to get on board, with the exception of generic painkillers and a few generic asthma medications.
In 2015, the U.S. Food and Drug Administration approved the first generic version of a drug, which is a generic version that is not patented.
This means the generic drug makers can get a drug that is cheaper than the drug they originally developed, and the drug companies can lower the prices of generic products.
Since the introduction of generic drug patents in the United States, generic drugs have been sold for around $50 per pill, or less than half of what they cost on the generic market.
The drug companies argue that generics are cheaper than their traditional counterparts because they don’t need to develop and test their own drugs.
In the last few years, the generic drugs market has seen significant price increases in many countries, as well as some generic medicines going on sale at prices below the cost of generic medications.
Many pharmaceutical companies have gone to great lengths to try and convince the public that generically made drugs are cheaper.
For example, some companies have been known to advertise that generic versions of their drugs cost between $1,500 and $3,000 per pill.
“We are committed to developing new and innovative products to help patients stay healthy and avoid side effects from medicines,” said Paul Bowers, vice president of the Generic Pharmaceutical Association, in a statement.
Some generic drugmakers have also made changes to their marketing to try to convince the market that they are cheaper drugs.
For instance, generic versions that use the same brand of medicine may contain different amounts of active ingredients, which could mean that the cost may be more expensive for some people.
Some generics also have additional costs, like testing and lab testing.
Generic drugs are more expensive than their conventional counterparts because of the cost they add to the price they charge for the drug.
One study by the Kaiser Family Foundation found that generic drugs cost about 2.8 percent more per year than generics produced by the same manufacturer.
The generic drug industry is also struggling to get its own patents approved.
Last year, the FDA issued a new rule that allows generic drugs to be patented, but it also required companies to file patents for their own drug.
This new rule has been met with some concern, especially from some of the pharmaceutical companies.
Since the patent process is not streamlined, some of these companies have not been able to move ahead with their own plans for filing their own patents.
This could result in fewer generic drugs being on the market and fewer people being able to afford to buy them.